CN103566132A - Traditional Chinese medicine composition for treating urolithiasis - Google Patents

Traditional Chinese medicine composition for treating urolithiasis Download PDF

Info

Publication number
CN103566132A
CN103566132A CN201310516791.9A CN201310516791A CN103566132A CN 103566132 A CN103566132 A CN 103566132A CN 201310516791 A CN201310516791 A CN 201310516791A CN 103566132 A CN103566132 A CN 103566132A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
urolithiasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310516791.9A
Other languages
Chinese (zh)
Inventor
陈浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Vocational and Technical College of Industry and Trade
Original Assignee
Anhui Vocational and Technical College of Industry and Trade
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Vocational and Technical College of Industry and Trade filed Critical Anhui Vocational and Technical College of Industry and Trade
Priority to CN201310516791.9A priority Critical patent/CN103566132A/en
Publication of CN103566132A publication Critical patent/CN103566132A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating urolithiasis. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-20 parts of poria, 5-15 parts of atractylodes macrocephala, 10-20 parts of magnolia obavata, 10-20 parts of eucommia ulmoides, 10-15 parts of Chinese yam, 5-15 parts of semen cuscutae, 10-20 parts of longhairy antenoron herbs, 10-15 parts of akebiaquinata, 10-15 parts of semen plantaginis, 10-20 parts of atractylodes macrocephala, 5-15 parts of chicken gizzard membranes, 5-15 parts of prepared fructus aurantii, 10-20 parts of pilose asiabell roots, 5-10 parts of liquorice and 10-20 parts of rheum officinale. The traditional Chinese medicine composition has the double effects of tonifying qi and reinforcing kidney to remove urinary calculus as well as inducing diuresis and treating stranguria to remove urinary calculus and is prepared according to the etiology and pathogenesis from two aspects including deficiency of kidney energy and hyperthermia of a patient suffering from urolithiasis so that the urolithiasis can be fundamentally treated and the recurrence of the urolithiasis can be prevented from being induced.

Description

A kind of Chinese medicine composition for the treatment of urinary system calculus
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of Chinese medicine composition for the treatment of urinary system calculus.
Background technology
Urinary system calculus (comprising renal calculus, ureteral calculus, wing skin calculus, calculus of urethra) is the common disease of Urology Surgery.Containing calcium calculus, be modal calculus type in renal calculus, account for 70%~80% of whole urinary system calculus.
In recent years along with development such as extracorporeal shock-wave lithotripsy (ESWL) and intracavity Urology Surgeries, the treatment of renal calculus makes considerable progress, but the problem that after renal calculus operative treatment, relapse rate is high is perplexing Urology Surgery doctor all the time, therefore pay attention to and strengthen preventing the measure of recurrence of hepatolithiasis to be absolutely necessary.Therefore in active treatment renal calculus, how to reduce the high risk factor that produces calculus, prevention recurrence of hepatolithiasis, no less important seems.
The cause of disease of urinary system calculus is very complicated, and it is relevant with the illness of natural environment, social condition, general metabolic disturbance and urinary system itself.At present substantially clear to the understanding of the local factor of urinary system itself, but comprehensive not enough to the understanding of the formation relation of general metabolic disturbance and urinary system calculus.
There is at present several different methods, comprise extracorporeal shock-wave lithotripsy (ESWL), PCN, various endoscopies get stone or lithotrity can be selected for us, and accumulated a large amount of experiences, only have a few patients to need traditional open surgery treatment, but the problem that after renal calculus operative treatment, relapse rate is high is perplexing Urology Surgery doctor all the time, from traditional Chinese medical science angle, it is controlled and can only take stopgap measures, be difficult to reach the object of effecting a permanent cure, and renal calculus operative treatment has certain indication, also there is certain complication, as: induced renal damage, postoperative fever, wound infection, septicemia, postoperative hemorrhage etc.And Chinese medicine has unique organic conception, a large amount of clinical researches has proved that Chinese medicine has unique advantage aspect treatment stranguria caused by urinary stone.Chinese medicine has in treatment renal calculus that curative effect is obvious, cheap, the feature such as have no side effect, and has made up operation, external stone crushing to microlith and muddy stone weak effect or invalid defect.
Summary of the invention
The Chinese medicine composition that the object of this invention is to provide a kind of determined curative effect, side effect treatment urinary system calculus little, with low cost.
The technical solution adopted in the present invention is as follows:
Treat a Chinese medicine composition for urinary system calculus, this Chinese medicine composition is made by the raw material of Chinese medicine of following portions by weight:
Poria 10~20 Rhizoma Atractylodis Macrocephalae 5~15 Cortex Magnoliae Officinalis 10~20
The Cortex Eucommiae 10~20 Rhizoma Dioscoreae 10~15 Semen Cuscutae 5~15
Herba Lysimachiae 10~20 Caulis Akebiae 10~15 Semen Plantaginiss 10~15
The Rhizoma Atractylodis Macrocephalae 10~20 Endothelium Corneum Gigeriae Galli 5~15 Fructus Aurantii 5~15 processed
Radix Codonopsis 10~20 Radix Glycyrrhizae 5~10 Radix Et Rhizoma Rhei 10~20.
Preferably, the Chinese medicine composition of described treatment urinary system calculus is made by the raw material of Chinese medicine of following portions by weight:
Poria 15 Rhizoma Atractylodis Macrocephalae 10 Cortex Magnoliae Officinalis 15
The Cortex Eucommiae 15 Rhizoma Dioscoreae 12 Semen Cuscutae 10
Herba Lysimachiae 15 Caulis Akebiae 12 Semen Plantaginiss 12
The Rhizoma Atractylodis Macrocephalae 15 Endothelium Corneum Gigeriae Galli 10 Fructus Aurantii 10 processed
Radix Codonopsis 15 Radix Glycyrrhizae 8 Radix Et Rhizoma Rhei 15.
Above-mentioned Chinese medicine composition routinely decocting method is directly taken after making decoction, also can get each raw material of Chinese medicine by formulation weight umber adds decocting and endures 4 times, each 1 hour, collecting decoction, after filtration, being condensed into relative density is that 1.1~1.2((water content is 50%) soft material, add 1~5 times of excipient, then after drying and crushing, pack into and in capsulae vacuus, make capsule.
Formula of the present invention rationally, determined curative effect, toxic and side effects be little, the raw material of Chinese medicine wide material sources that use in formula, with low cost.
Herba Lysimachiae, Spora Lygodii, Endothelium Corneum Gigeriae Galli in the present invention's formula is the classical prescription of calculus removing, there is inducing diuresis for treating stranguria syndrome, change the effect of hard Sal Nitri and pain relieving, be aided with the invigorating vital QI components such as Poria, Radix Glycyrrhizae, make the present invention there is vital energy benefiting and the kidney invigorating calculus and dampness removing Tonglin Paishi double effects, for urinary system calculus patient, suffer from a deficiency of the kidney and warm two aspect etiology and pathogenesis, can fundamentally treat the recurrence of urinary system calculus and prevention calculus.
The specific embodiment
Embodiment 1
Formula is:
Poria 15 Rhizoma Atractylodis Macrocephalae 10 Cortex Magnoliae Officinalis 15
The Cortex Eucommiae 15 Rhizoma Dioscoreae 12 Semen Cuscutae 10
Herba Lysimachiae 15 Caulis Akebiae 12 Semen Plantaginiss 12
The Rhizoma Atractylodis Macrocephalae 15 Endothelium Corneum Gigeriae Galli 10 Fructus Aurantii 10 processed
Radix Codonopsis 15 Radix Glycyrrhizae 8 Radix Et Rhizoma Rhei 15.
Preparation method is: by above-mentioned weight, get each raw material of Chinese medicine and add decocting and endure 4 times, each 1 hour, collecting decoction, after filtration, be condensed into the soft material of relative density 1.2, add 3 times of excipient (dextrin and sucrose, weight ratio is 1:2), then after drying and crushing, fill No. 3 capsulae vacuuses and obtain Chinese medicinal composition capsules agent of the present invention (0.3 gram /), instructions of taking is 3 times on the one, each 3.Or by above-mentioned weight, get each raw material of Chinese medicine and add after decocting to obtain the about 300ml of medicinal liquid, 1 dose of every day, minutes 2 times are oral.
Embodiment 2
Formula is:
Poria 10~20 Rhizoma Atractylodis Macrocephalae 5~15 Cortex Magnoliae Officinalis 10~20
The Cortex Eucommiae 10~20 Rhizoma Dioscoreae 10~15 Semen Cuscutae 5~15
Herba Lysimachiae 10~20 Caulis Akebiae 10~15 Semen Plantaginiss 10~15
The Rhizoma Atractylodis Macrocephalae 10~20 Endothelium Corneum Gigeriae Galli 5~15 Fructus Aurantii 5~15 processed
Radix Codonopsis 10~20 Radix Glycyrrhizae 5~10 Radix Et Rhizoma Rhei 10~20.
Embodiment 3
Formula is:
Poria 10~20 Rhizoma Atractylodis Macrocephalae 5~15 Cortex Magnoliae Officinalis 10~20
The Cortex Eucommiae 10~20 Rhizoma Dioscoreae 10~15 Semen Cuscutae 5~15
Herba Lysimachiae 10~20 Caulis Akebiae 10~15 Semen Plantaginiss 10~15
The Rhizoma Atractylodis Macrocephalae 10~20 Endothelium Corneum Gigeriae Galli 5~15 Fructus Aurantii 5~15 processed
Radix Codonopsis 10~20 Radix Glycyrrhizae 5~10 Radix Et Rhizoma Rhei 10~20.
Model case 1: Mr. Wang, 46 years old, occurred the right lumbar region angor without obvious inducement before 1 year, spontaneous remission after a few hours, without heating, nauseating, vomiting, right side renal calculus is found in ultrasound diagnosis, give remission after medicine lithagogue treatment, once, check B ultrasonic shows right side renal calculus (4mm * 4mm), takes capsule of the present invention in rear approximately outbreak in 1 month, 3 times on the one, each 4, and advise every daily drink 2000ml and do jumping exercise more, after 30 days, check B ultrasonic and show that left side renal calculus disappears.
Model case 2: Mr. Liu, 42 years old, before one month, without obvious inducement, there is right side waist and belly paroxysmal pain, time sharp ache occur hematuria, ultrasound diagnosis shows right Renal sinus separation, the strong echo of interior visible big or small about 5mm * 5mm group accompanying sound shadow, gives spasmolytic, pain relieving symptomatic treatment, takes capsule of the present invention, 3 times on the one, each 4, and advise every daily drink 2000ml and do jumping exercise more, after 30 days, check B ultrasonic and show that right side renal calculus disappears.

Claims (3)

1. treat a Chinese medicine composition for urinary system calculus, it is characterized in that this Chinese medicine composition made by the raw material of Chinese medicine of following portions by weight:
Poria 10~20 Rhizoma Atractylodis Macrocephalae 5~15 Cortex Magnoliae Officinalis 10~20
The Cortex Eucommiae 10~20 Rhizoma Dioscoreae 10~15 Semen Cuscutae 5~15
Herba Lysimachiae 10~20 Caulis Akebiae 10~15 Semen Plantaginiss 10~15
The Rhizoma Atractylodis Macrocephalae 10~20 Endothelium Corneum Gigeriae Galli 5~15 Fructus Aurantii 5~15 processed
Radix Codonopsis 10~20 Radix Glycyrrhizae 5~10 Radix Et Rhizoma Rhei 10~20.
2. according to a kind of Chinese medicine composition for the treatment of urinary system calculus claimed in claim 1, it is characterized in that this Chinese medicine composition made by the raw material of Chinese medicine of following portions by weight:
Poria 15 Rhizoma Atractylodis Macrocephalae 10 Cortex Magnoliae Officinalis 15
The Cortex Eucommiae 15 Rhizoma Dioscoreae 12 Semen Cuscutae 10
Herba Lysimachiae 15 Caulis Akebiae 12 Semen Plantaginiss 12
The Rhizoma Atractylodis Macrocephalae 15 Endothelium Corneum Gigeriae Galli 10 Fructus Aurantii 10 processed
Radix Codonopsis 15 Radix Glycyrrhizae 8 Radix Et Rhizoma Rhei 15.
3. according to a kind of Chinese medicine composition for the treatment of urinary system calculus described in claim 1 or 2, the dosage form that it is characterized in that described Chinese medicine composition is decoction or capsule.
CN201310516791.9A 2013-10-25 2013-10-25 Traditional Chinese medicine composition for treating urolithiasis Pending CN103566132A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310516791.9A CN103566132A (en) 2013-10-25 2013-10-25 Traditional Chinese medicine composition for treating urolithiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310516791.9A CN103566132A (en) 2013-10-25 2013-10-25 Traditional Chinese medicine composition for treating urolithiasis

Publications (1)

Publication Number Publication Date
CN103566132A true CN103566132A (en) 2014-02-12

Family

ID=50039413

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310516791.9A Pending CN103566132A (en) 2013-10-25 2013-10-25 Traditional Chinese medicine composition for treating urolithiasis

Country Status (1)

Country Link
CN (1) CN103566132A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288027A (en) * 2015-11-30 2016-02-03 姜晓红 Traditional Chinese medicine composition for curing urinary calculi
CN105560989A (en) * 2016-01-11 2016-05-11 郭峰 Traditional Chinese medicine composition for treating renal calculus and urethral calculus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302735A (en) * 2011-08-26 2012-01-04 陈遇献 Calculus removing medicine
CN102813791A (en) * 2012-08-01 2012-12-12 河南科技大学 Traditional Chinese medicine composition for treating kidney stone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102302735A (en) * 2011-08-26 2012-01-04 陈遇献 Calculus removing medicine
CN102813791A (en) * 2012-08-01 2012-12-12 河南科技大学 Traditional Chinese medicine composition for treating kidney stone

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
李华荣: "中药治疗泌尿系统结石的中文文献分析", 《中国药业》 *
李学明: "通淋化瘀排石汤治疗泌尿系结石98例", 《四川中医》 *
王玲等: "中成药治疗泌尿系统结石的研究进展", 《医药导报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288027A (en) * 2015-11-30 2016-02-03 姜晓红 Traditional Chinese medicine composition for curing urinary calculi
CN105560989A (en) * 2016-01-11 2016-05-11 郭峰 Traditional Chinese medicine composition for treating renal calculus and urethral calculus

Similar Documents

Publication Publication Date Title
CN102813791B (en) Traditional Chinese medicine composition for treating kidney stone
CN101396542A (en) Traditional Chinese medicine formulation for treating gastrosis and preparation method thereof
CN103566133A (en) Traditional Chinese medicine composition for treating kidney stone
CN104888097A (en) Traditional Chinese medicine composition for preventing urinary calculus, and application thereof
CN102343008B (en) Chinese medicinal composition for treating prolapse of lumbar intervertebral disc
CN104758762A (en) Traditional Chinese medicine composition for treating tuberculosis
CN103566132A (en) Traditional Chinese medicine composition for treating urolithiasis
CN1330355C (en) Chinese medicinal composition for treating ulcer
CN104547747A (en) Fast-acting medicinal liquor for treating wind-cold-dampness arthralgia and application thereof
CN102908423A (en) Chinese medicinal composition for treating stones
CN105213831A (en) A kind of Chinese medicine composition for the treatment of epidemic hemorrhagic fever
CN102188510B (en) Traditional Chinese medicine composition for treating sand-like cholelithiasis
CN104337919A (en) Internal medicine for treating nasosinusitis and preparation method thereof
CN104922434A (en) Decoction medicine for treating polyp of vocal cord and preparation method thereof
CN103285108B (en) Chinese medicinal composition treating lumbago
CN103028054B (en) Traditional Chinese medicine composition for treating stranguria
CN103251901A (en) Oral traditional Chinese medicine preparation for treating dysmenorrhea
CN103223113B (en) Traditional Chinese medicine composition for treating functional uterine bleeding
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN102284023A (en) Chinese medicinal composition for treating asthma
CN106692940B (en) A sterile oral liquid for children and its preparation method
CN105663870A (en) Traditional Chinese medicinal composition for treating hydronephrosis
CN104984116A (en) Traditional Chinese medicine composition for treating kidney stone
CN104623368A (en) Decoction medicine for treating chronic glomerulonephritis and preparation method thereof
CN103599194A (en) Traditional Chinese medicinal composition for removing calculi

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140212